The Body Rebuilt | Ginger Sparks No. 23
Cryonics, donor fat, and the hormone panic: what it looks like when beauty and wellness stop treating symptoms and start arguing about the system itself.
This week's sparks go places. We are looking at a longevity practice that started with Benjamin Franklin and now has a 4,000-person waitlist, a body filler made from donor fat that is reshaping the GLP-1 conversation, and the cortisol algorithm that arrived years before medicine did. As always, we bring receipts.
Freeze Now, Come Back Later
Well, turns out the longevity class does not plan to die. They plan to freeze and come back later. In 1773, Benjamin Franklin wrote that he would rather be preserved in a cask of Madeira wine than face an ordinary death, to be revived at a future date of his choosing. It took 250 years, but the waiting list now has 4,000 names. Simon Cowell, Paris Hilton, Steve Aoki, and Peter Thiel have all publicly discussed their desire to be preserved. In a January 2026 episode of her podcast, Khloé in Wonder Land, Khloé Kardashian said she would have her body frozen, adding that she would live to 104 as long as she still looked good.
In Rory Satran’s May 2026 Town & Country investigation, cryonics feels less like science fiction than it ever has before. The scientific establishment remains split. Many medical professionals dismiss the practice outright, but proponents point to egg freezing, cloning, and organ transplantation as proof that the distance between science fiction and clinical reality keeps closing. ( What a time to be alive!) Tomorrow Bio, which started in Berlin and now operates in New York, California, and Florida, published a 2026 roadmap focused on faster-response logistics and improved preservation quality. The Global Wellness Summit’s 2026 trends report frames longevity as no longer a service you visit but a lifestyle you live in. Cryonics is simply the most extreme expression of that exact idea.
And then there is Dale Pearce, an Australian game developer who traveled 10,000 miles and spent nearly $40,000 to cryogenically freeze his terminally ill dog Neren at a facility in Michigan. He plans to freeze himself, too, so they can be revived together. We are not making this up!
Ginger Spark: We are living in the future, and the beauty and wellness industry is proof of it. The same conviction behind stem cell tourism, biological age testing, and regenerative aesthetics is powering the cryonics revival. The question is no longer science fiction. It is whether we are the first generation to get to choose between living better for longer and not leaving at all. Fascinating stuff!
Replace Like With Like
Fat is having a moment in aesthetics, and the reasoning behind it is more compelling than it sounds. GLP-1 drugs have created an unexpected problem: patients are losing weight faster than anyone planned for, and are left with volume loss they cannot address surgically because they no longer have enough body fat of their own to transfer. alloClae™, a first-of-its-kind body filler from Tiger Aesthetics, was built for exactly this problem. Made from purified donor fat processed into a shelf-stable injectable, it skips the liposuction entirely. The philosophy driving it is simple: replace like with like.
Surgeons have pulled from cadaver tissue for bone grafts, cartilage repair, and skin reconstruction throughout the history of medicine. alloClae™ applies the same logic to aesthetics. Renuva, made by MTF Biologics, has been doing this for facial corrections for years. alloClae™ is the body-scaled version, and that distinction is what has the industry paying attention.
Allure broke it down in November 2025, and the conversation has only accelerated since. Glossy, NewBeauty, and RealSelf have all flagged it as one of the defining treatments of 2026. Board-certified Austin plastic surgeon Dr. Johnny Franco calls his practice a “regenerative playground” and described alloClae™ as “hands down the most exciting product to hit the market in 2025.” Allure notes that surgeons with access to a patient’s own fat still tend to prefer it, citing the advantage of living tissue. The consensus seems to be that alloClae™ earns its place for patients without that option. The “zombie filler” nickname has taken hold on social media, and Gloss Angeles dedicated an entire episode to it this month. As The Week noted in April, some surgeons worry the industry is moving too fast without adequate follow-up studies. If this is on your radar, your plastic surgeon is the right person to call first.
Ginger Spark: Aesthetic medicine is finally asking a better question. Not what can we add, but what can we restore. That question is now driving everything from surgical body fillers to PDRN serums to biostimulators that teach your skin to produce its own collagen. The through line is the same: work with biology, not around it. alloClae™ is the most dramatic version of that idea. But the philosophy is already showing up on your vanity.
The Algorithm Diagnosed You
The concept of hormone imbalance is all over social media right now, and honestly, it is tricky and confusing territory. Perimenopause has become one of the hottest topics online, with Gen Z and elder millennials deep in the research well before symptoms arrive. Google searches for cortisol have hit record highs in 2026, nearly doubling since the start of the year. “Cortisol face,” a social media rebrand of puffy cheeks and under-eye bags, spawned an entire product category almost overnight. The symptoms driving all of this feel real because they often are. The science behind the solutions is where things get complicated.
Clinically, the picture is more nuanced than the algorithm suggests. Hormones are not static. They fluctuate constantly across the menstrual cycle, across stress levels, and across the day, which means a single cortisol reading tells you almost nothing useful in isolation. As Fashionista reported, board-certified endocrinologist Dr. Caroline Messer notes that an actual Cushing syndrome diagnosis, the condition involving genuinely elevated cortisol, can take upwards of ten years to confirm. Meanwhile, cortisol gummies and adrenal cocktails arrive the next day. A 2026 peer-reviewed case report found that a woman who took high-dose ashwagandha daily for a year developed adrenal insufficiency as a result. The supplement meant to lower her cortisol suppressed her adrenal function entirely. While ashwagandha is long known for its use in traditional Indian medicine (Ayurveda), one must consult their physicians on any usage/drug interaction, since it can stimulate the thyroid gland, potentially benefiting those with an underactive thyroid, but an issue for those with hyperthyroidism, along with other risks. Grand View Research estimates the U.S. supplement market at nearly $69 billion in 2025. Someone is doing very well on this confusion.
The products are almost beside the point. What the supplement aisle found was a genuine systemic failure in women’s healthcare, and it moved in faster than medicine could. Only 31% of ob-gyn residency programs in the U.S. include menopause in their curriculum. Menopause-related work disruptions cost the U.S. roughly $1.8 billion in lost productivity every year. Women are not imagining their symptoms. They are being failed by a system with no time for them and turning to an algorithm that has all the time in the world. Harper’s Bazaar’s “Balancing Act” captures this tension better than anything we have read recently.
Ginger Spark: The hormone conversation is not going away, and it deserves a better answer than ashwagandha gummies. The demand is enormous, legitimate, and almost entirely underserved by mainstream medicine. Whoever builds the personalized, accessible hormone care that closes that gap will own the next decade of women’s health.
